🟢 Decoy Therapeutics is trading 11.25% up in pre-market despite no new company-specific catalyst

Decoy Therapeutics is trading 11.25% up at $3.56 after no new company-specific catalyst was identified for August 24, 2026.

• Its latest reported developments were an August 12 second-quarter loss and an August 3 intellectual-property update, both predating this move.
• Broader markets are slightly weaker and do not clearly explain the gains.
• The move may reflect speculative or delayed trading activity; the catalyst remains unconfirmed.